EQUITY (Detail Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Mar. 27, 2026 |
Jan. 30, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jan. 29, 2026 |
Dec. 31, 2025 |
Oct. 28, 2025 |
|
| Preferred stock, par value | $ 0.001 | $ 0.001 | |||||
| Aggregate value | $ 10,033,000 | ||||||
| Preferred stock, shares authorized | 23,148 | 23,148 | |||||
| Stock-based compensation | $ 256,000 | $ 192,000 | |||||
| Preferred stock, shares issued | 0 | 0 | |||||
| Preferred stock, shares outstanding | 0 | 0 | |||||
| Intrinsic value of the warrants | $ 52,016,000 | ||||||
| Common stock par value | $ 0.001 | $ 0.001 | $ 0.001 | ||||
| Common stock, shares authorized | 166,666,667 | 166,666,667 | |||||
| Common stock, shares issued | 876,032 | 673,008 | |||||
| Common stock, shares outstanding | 673,008 | 673,008 | |||||
| 2018 Equity Incentive Plan [Member] | |||||||
| Common stock reserved for future issuance | 100,938 | ||||||
| Common stock, shares issuable | 212,793 | ||||||
| Common stock, shares available to be issued | 7,275 | ||||||
| Equity Agreement [Member] | |||||||
| Initial commitment amount | $ 25,000 | ||||||
| Additional initial commitment amount | $ 25,000 | ||||||
| Number of shares issued, shares | 35,342 | ||||||
| Number of pre funded warrants issued, shares | 62,124 | ||||||
| Number of pre funded warrants purchased | 62,124 | ||||||
| Exercise price, per share | $ 0.003 | ||||||
| Aggregate value | $ 500 | ||||||
| Cash fee, percent | 8.00% | ||||||
| Number of warrants issued to purchase common stock | 255,073 | ||||||
| Warrants exercise price | $ 4.3125 | ||||||
| Gross proceeds from the offering | $ 10,997 | ||||||
| Gross proceeds from the offering if Warrants are fully exercised for cash | 31,400 | ||||||
| Net proceeds from the offering | $ 10,032 | ||||||
| Description of pre-funded warrants | (i) 81,000 shares (the “Shares”) of the Company’s common stock at $3.45 per share, (ii) pre-funded warrants to purchase 3,107,407 shares of common stock at an exercise price of $0.001 per share (the “Pre-Funded Warrants”), and (iii) warrants to purchase 6,376,814 shares of common stock at an exercise price of $3.20 per share (the “Common Warrants”). The Pre-Funded Warrants and the Common Warrants are collectively referred to herein as the “Warrants” and the shares issuable upon such Warrants, the “Warrant Shares.” Each Share or, at the election of the Purchaser in lieu of Shares, each Pre-Funded Warrant, was issued and sold along with two Common Warrants. The combined purchase price for the securities was (i) $3.45 per Share and two Common Warrants, and (ii) $3.449 per Pre-Funded Warrant and two Common Warrants. The offering closed on March 30, 2026. | ||||||
| Valuation [Member] | |||||||
| Options granted | 129,520 | ||||||
| Option granted, value | $ 533,000 | ||||||
| Stock option expense, unamortized | 845,000 | ||||||
| Options outstanding, intrinsic value | $ 329,000 | $ 0 | |||||
| Valuation [Member] | Related Parties [Member] | |||||||
| Options granted | 67,790 | ||||||
| Option granted, value | $ 279,000 | ||||||
| Stock option expense, unamortized | $ 413,000 | ||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|